Scheit KH - Search Results

1

[Adjuvant immunotherapy with keyhole limpet hemocyanin in category PT 2 N+ and PT 3-4, No-N+, Mo renal cell carcinoma].

Jurincic-Winkler CD, Horlbeck R, von der Kammer H, Scheit KH, Klippel KF. Jurincic-Winkler CD, et al. Among authors: scheit kh. Wien Klin Wochenschr. 1994;106(14):455-8. Wien Klin Wochenschr. 1994. PMID: 7941592 Clinical Trial. German.

2

Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.

Jurincic-Winkler CD, von der Kammer H, Beuth J, Scheit KH, Klippel KF. Jurincic-Winkler CD, et al. Among authors: scheit kh. Anticancer Res. 1996 Jul-Aug;16(4A):2105-10. Anticancer Res. 1996. PMID: 8712751 Clinical Trial.

3

The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostatic tumor.

von der Kammer H, Jurincic-Winkler C, Horlbeck R, Klippel KF, Pixberg HU, Scheit KH. von der Kammer H, et al. Among authors: scheit kh. Urol Res. 1993 May;21(3):227-33. doi: 10.1007/BF00590041. Urol Res. 1993. PMID: 7688168

4

Characterization of a monoclonal antibody specific for prostatic secretory protein of 94 amino acids (PSP94) and development of a two-site binding enzyme immunoassay for PSP94.

von der Kammer H, Krauhs E, Aumüller G, Scheit KH. von der Kammer H, et al. Among authors: scheit kh. Clin Chim Acta. 1990 Mar 15;187(3):207-19. doi: 10.1016/0009-8981(90)90106-3. Clin Chim Acta. 1990. PMID: 2323061

5

Clinical evaluation of a new prostate-specific antigen sandwich ELISA which employs four monoclonal antibodies directed at different epitopes of prostate-specific antigen.

Jurincic-Winkler C, von der Kammer H, Horlbeck R, Klippel KF, Pixberg HU, Scheit KH. Jurincic-Winkler C, et al. Among authors: scheit kh. Eur Urol. 1993;24(4):487-91. doi: 10.1159/000474356. Eur Urol. 1993. PMID: 7507048

6

Development and evaluation of an enzyme-linked immunoassay for the prostate: specific antigen utilizing two monoclonal antibodies.

Zundel D, Jarry H, Kestler D, Holzapfel G, Bartels H, Scheit KH, Wuttke W. Zundel D, et al. Among authors: scheit kh. Urol Res. 1990;18(5):327-30. doi: 10.1007/BF00300781. Urol Res. 1990. PMID: 1701585

7

The evaluation of markers of prostatic function.

von der Kammer H, Scheit KH, Weidner W, Cooper TG. von der Kammer H, et al. Among authors: scheit kh. Urol Res. 1991;19(6):343-7. doi: 10.1007/BF00310147. Urol Res. 1991. PMID: 1722055

8

Cloning and sequence analysis of a cDNA from human ovarian granulosa cells encoding the C-terminal part of human elongation factor 2.

Rapp G, Mucha J, Einspanier R, Luck M, Scheit KH. Rapp G, et al. Among authors: scheit kh. Biol Chem Hoppe Seyler. 1988 Apr;369(4):247-50. doi: 10.1515/bchm3.1988.369.1.247. Biol Chem Hoppe Seyler. 1988. PMID: 2840927

9

Re: Gamma-seminoprotein--a new tumour marker in prostatic cancer?

Scheit KH. Scheit KH. Br J Urol. 1991 Sep;68(3):331-2. Br J Urol. 1991. PMID: 1717099 No abstract available.

10

Amino acid sequence of seminalplasmin, an antimicrobial protein from bull semen.

Theil R, Scheit KH. Theil R, et al. Among authors: scheit kh. EMBO J. 1983;2(7):1159-63. doi: 10.1002/j.1460-2075.1983.tb01561.x. EMBO J. 1983. PMID: 16453469 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results